Novartis AG(us:NVS)

    97.11

    +0.35%

    Updated on 2024-12-22

    Open:96.16
    Close:97.11
    High:97.59
    Low:96.06
    Pre Close:96.77
    Volume:1.55M
    Amount:150.20M
    Turnover:0.08%
    Shares:2.00B
    MarketCap:194.15B
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-30629097460.04%71322
    2024-03-3112981396745506.84%87420535
    2023-12-3112941402753126.86%127389507
    2023-09-3013481481568057.20%89349624
    2023-06-3013542065928049.99%142355579
    2023-03-3112061709421648.15%81343560
    2022-12-3112121709906968.06%158296549
    2022-09-3011441792823018.33%56314538
    dateorgNametotalratiochangeShareschangeRatio
    2024-06-30Dodge & Cox122365260.60%-117459-0.95%
    2024-06-30Primecap Management Co/Ca/121793450.60%-238410-1.92%
    2024-06-30Morgan Stanley74166790.37%1582982.18%
    2024-06-30Dimensional Fund Advisors Lp74076920.37%138961023.09%
    2024-06-30Loomis Sayles & Co L P59453830.29%274110.46%
    2024-06-30Franklin Resources Inc53394900.26%-360299-6.32%
    2024-06-30Bank Of America Corp /De/48450530.24%-43140-0.88%
    2024-06-30Wellington Management Group Llp43846500.22%-204700-4.46%
    2024-06-30Goldman Sachs Group Inc30810760.15%217150.71%
    2024-06-30Cullen Capital Management, Llc28703810.14%-54043-1.85%

    About

    Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
    Address:Lichtstrasse 35

    Market Movers